Literature DB >> 26043071

Elevated serum complement C3 levels are related to the development of prediabetes in an adult population: the Tianjin Chronic Low-Grade Systematic Inflammation and Health Cohort Study.

X Bao1, Y Xia1, Q Zhang2, H M Wu1, H M Du1, L Liu2, C J Wang2, H B Shi2, X Y Guo1, X Liu1, C L Li1, Q Su1, G Meng1,3, B Yu1,4, S M Sun2, X Wang2, M Zhou2, Q Y Jia2, K Song2, K J Niu1,2.   

Abstract

AIMS: To investigate whether serum complement C3 is related to the prevalence and incidence of prediabetes in an adult population.
METHODS: A cross-sectional (n = 10 206) and prospective cohort study (n = 3333), with a mean (range; 95% CI) follow-up of 2.63 (1-6; 2.58-2.68) years, was conducted in people recruited from the Health Management Centre of Tianjin Medical University General Hospital in Tianjin, China. Measurement of serum C3 concentration, blood fasting glucose, oral glucose tolerance, HbA1c and other potential confounding factors was performed at baseline and each year during the follow-up. Prediabetes was defined according to the criteria of the American Diabetes Association. Adjusted logistic and Cox proportional hazards regression models were used to assess the relationships between C3 quintiles and prediabetes.
RESULTS: The prevalence and incidence of prediabetes were 38.5% and 119 per 1000 person-years, respectively. In cross-sectional analysis, after adjustment for potential confounders, the odds ratios of prediabetes for increasing quintiles of C3 were 1.00 (reference), 1.32 (95% CI 1.14-1.53), 1.37 (95% CI 1.18-1.59), 1.75 (95% CI 1.51-2.03), 2.25 (95% CI 1.93-2.62; P for trend < 0.0001). In the cohort analysis, the multiple-adjusted hazard ratio of prediabetes in the highest quintile of baseline C3 was 1.43 (95% CI 1.15, 1.78; P for trend < 0.001), when compared with the lowest quintile.
CONCLUSIONS: These findings indicate that elevated serum C3 levels are significantly related to an increased risk of developing prediabetes in an adult population, suggesting that C3 can be used as a biomarker in high-risk individuals to improve primary prevention of prediabetes and diabetes.
© 2015 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26043071     DOI: 10.1111/dme.12827

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  5 in total

1.  The mediated role of complement C3 in PM2.5 exposure and type 2 diabetes mellitus: an elderly panel study in Beijing, China.

Authors:  Yuanren Tong; Lu Pei; Kai Luo; Meiduo Zhao; Jing Xu; Ang Li; Runkui Li; Mingan Yang; Qun Xu
Journal:  Environ Sci Pollut Res Int       Date:  2019-10-22       Impact factor: 4.223

2.  Protective Role of Complement C3 Against Cytokine-Mediated β-Cell Apoptosis.

Authors:  Reinaldo S Dos Santos; Laura Marroqui; Fabio A Grieco; Lorella Marselli; Mara Suleiman; Stefan R Henz; Piero Marchetti; Rasmus Wernersson; Decio L Eizirik
Journal:  Endocrinology       Date:  2017-08-01       Impact factor: 4.736

3.  Serum complement C3 and islet β-cell function in patients with type 2 diabetes: A 4.6-year prospective follow-up study.

Authors:  Jian-Bin Su; Yun-Yu Wu; Feng Xu; Xing Wang; Hong-Li Cai; Li-Hua Zhao; Xiu-Lin Zhang; Tong Chen; Hai-Yan Huang; Xue-Qin Wang
Journal:  Endocrine       Date:  2019-11-30       Impact factor: 3.633

4.  The inflammatory effects of TNF-α and complement component 3 on coagulation.

Authors:  Martin J Page; Janette Bester; Etheresia Pretorius
Journal:  Sci Rep       Date:  2018-01-29       Impact factor: 4.379

5.  Comparing the inflammatory profiles for incidence of diabetes mellitus and cardiovascular diseases: a prospective study exploring the 'common soil' hypothesis.

Authors:  Xue Bao; Yan Borné; Linda Johnson; Iram Faqir Muhammad; Margaretha Persson; Kaijun Niu; Gunnar Engström
Journal:  Cardiovasc Diabetol       Date:  2018-06-12       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.